Search alternatives:
point decrease » point increase (Expand Search)
g decrease » _ decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 g » 5 mg (Expand Search)
point decrease » point increase (Expand Search)
g decrease » _ decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 g » 5 mg (Expand Search)
-
19841
-
19842
Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis
Published 2020“…Immune profiles of TNBCs in a cohort of “good outcome” (no relapse within 5 years) patients were also analyzed. …”
-
19843
Data obtained from monitoring patients.
Published 2023“…Three decreasing values of immunoglobulin G were a security parameter for stopping the child’s medication in the exposed group (50/61). …”
-
19844
General characteristics and statistical analysis.
Published 2023“…Three decreasing values of immunoglobulin G were a security parameter for stopping the child’s medication in the exposed group (50/61). …”
-
19845
-
19846
-
19847
-
19848
S1 File -
Published 2024“…No significant changes in vertical ground reaction force at the turning point were observed. High load AEL conditions (20% and 30% body weight) led to slight reductions in jump height, primarily due to decreased hip joint and centre of mass work. …”
-
19849
-
19850
-
19851
-
19852
-
19853
Table_5_Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer.xlsx
Published 2023“…</p>Results<p>In the luminal A breast cancer, a total of 5,044 high-confidence proteins and 3,808 phosphoproteins were identified from 10 paired tissues. …”
-
19854
Schematic overview of the experimental groups.
Published 2025“…Post-treatment, the test group displayed reduced food intake (163 ± 2 g vs. 197 ± 6 g), body weight (297 ± 2 g vs. 376 ± 6 g), blood glucose (5.8 ± 0.3 mmol/L vs. 9.8 ± 0.2 mmol/L), and improved glucose tolerance (711 ± 14 vs. 853 ± 9 mmol/L·min) compared to negative controls (p < 0.0001). …”
-
19855
-
19856
Effect of rPVH1-yCD/5FC treatment on NFκB and Akt/PI3K activity.
Published 2013“…The specificity of the band corresponding to NFκB-DNA complex was determined using non-labeled NFκB consensus oligonucleotide as a specific competitor. <b>C</b>) wtPV-H1 and rPVH1-yCD/5-FC decrease Akt/PI3K constitutive activity. …”
-
19857
-
19858
-
19859
-
19860